ArticleOncology letters2018

γδ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors.

Wei Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.